ASGR1 and liver disorder: Other described ASGPR‐binding probes for PET imaging of further liver diseases rely on β‐d‐galactose (d‐Gal)[25, 26, 27] to increase affinity for ASGPR and these probes were conjugated to human serum albumin (HSA) to prolong half‐life in blood circulation.[18, 20, 26, 27] A few other approaches to use molecular tracers in nonalcoholic fatty liver (NAFLD) imaging using tryptophan‐rich sensory protein, Integrin αvβ3 or GSA receptors have been attempted but the animal mouse models used in these studies were not clinically translatable to humans.[28]